输尿管癌

来自妙佑医疗国际员工
Oct. 07, 2026

研究

妙佑医疗国际的医生和科学家正在研究诊断和治疗输尿管癌的新方法。

著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在输尿管癌领域的著述目录。

  1. Bladder cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1437. Accessed June 14, 2024.
  2. Partin AW, et al., eds. Urothelial tumors of the upper urinary tract and ureter. In: Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed July 24, 2024.
  3. Gupta S, et al. Malignancies of the renal pelvis and ureter. https://www.uptodate.com/contents/search. Accessed July 24, 2024.
  4. DeVita VT Jr, et al., eds. Cancer of the bladder, ureter and renal pelvis. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. ProQuest Ebook Central. Wolters Kluwer; 2023. Accessed June 14, 2024.
  5. Hematuria (blood in the urine). National Institute of Diabetes and Digestive and Kidney Disorders. https://www.niddk.nih.gov/health-information/urologic-diseases/hematuria-blood-urine. Accessed Aug. 16, 2024.
  6. Antioxidants and cancer prevention. National Cancer Institute. https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/antioxidants-fact-sheet. Accessed Aug. 16, 2024.
  7. Powles T, et al. Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. New England Journal of Medicine. 2024; doi:10.1056/NEJMoa2312117.
  8. Medical review (expert opinion). Mayo Clinic. Aug. 26, 2024.